MGP Ingredients, Inc. (MGPI)
NASDAQ: MGPI · Real-Time Price · USD
28.28
-1.09 (-3.71%)
At close: Jul 31, 2025, 4:00 PM
28.51
+0.23 (0.81%)
After-hours: Jul 31, 2025, 4:57 PM EDT
Verve Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 609.4 | 703.63 | 836.52 | 782.36 | 626.72 | 395.52 | Upgrade | |
Revenue Growth (YoY) | -22.65% | -15.89% | 6.92% | 24.83% | 58.45% | 9.04% | Upgrade |
Cost of Revenue | 367.4 | 417.31 | 531.81 | 529.05 | 448.81 | 300.5 | Upgrade |
Gross Profit | 242.01 | 286.32 | 304.71 | 253.31 | 177.91 | 95.03 | Upgrade |
Selling, General & Admin | 117.16 | 121.78 | 127.55 | 104.34 | 80 | 44.57 | Upgrade |
Operating Expenses | 117.16 | 121.78 | 127.55 | 104.34 | 80 | 44.57 | Upgrade |
Operating Income | 124.85 | 164.53 | 177.16 | 148.97 | 97.91 | 50.46 | Upgrade |
Interest Expense | -7.97 | -8.44 | -6.65 | -5.45 | -4.04 | -2.27 | Upgrade |
Earnings From Equity Investments | 1.21 | 1.83 | -0.34 | -2.22 | - | - | Upgrade |
Other Non Operating Income (Expenses) | 0.88 | 0.63 | 0.12 | -1.12 | -1.23 | 0.63 | Upgrade |
EBT Excluding Unusual Items | 118.98 | 158.55 | 170.3 | 140.17 | 92.64 | 48.82 | Upgrade |
Merger & Restructuring Charges | -0.24 | -0.25 | -21.45 | - | -11.46 | - | Upgrade |
Impairment of Goodwill | -73.76 | -73.76 | - | - | - | - | Upgrade |
Other Unusual Items | -29.3 | -16.1 | -7.1 | - | - | - | Upgrade |
Pretax Income | 15.82 | 68.44 | 141.75 | 140.17 | 121.1 | 52.6 | Upgrade |
Income Tax Expense | 22.59 | 33.98 | 34.62 | 31.3 | 30.28 | 12.26 | Upgrade |
Earnings From Continuing Operations | -6.77 | 34.47 | 107.13 | 108.87 | 90.82 | 40.35 | Upgrade |
Minority Interest in Earnings | 0.11 | 0.2 | 0.35 | 0.59 | 0.49 | - | Upgrade |
Net Income | -6.66 | 34.66 | 107.48 | 109.46 | 91.31 | 40.35 | Upgrade |
Preferred Dividends & Other Adjustments | -0.09 | 0.37 | 1.07 | 0.87 | 0.71 | 0.26 | Upgrade |
Net Income to Common | -6.57 | 34.29 | 106.4 | 108.59 | 90.6 | 40.08 | Upgrade |
Net Income Growth | - | -67.75% | -1.81% | 19.88% | 126.32% | 4.00% | Upgrade |
Shares Outstanding (Basic) | 22 | 22 | 22 | 22 | 21 | 17 | Upgrade |
Shares Outstanding (Diluted) | 22 | 22 | 22 | 22 | 21 | 17 | Upgrade |
Shares Change (YoY) | -2.53% | -0.71% | 0.54% | 6.44% | 22.33% | -0.44% | Upgrade |
EPS (Basic) | -0.30 | 1.56 | 4.82 | 4.94 | 4.37 | 2.37 | Upgrade |
EPS (Diluted) | -0.30 | 1.56 | 4.80 | 4.92 | 4.37 | 2.37 | Upgrade |
EPS Growth | - | -67.55% | -2.44% | 12.59% | 84.65% | 4.47% | Upgrade |
Free Cash Flow | 59.11 | 31.1 | 28.52 | 43.61 | 40.87 | 33.55 | Upgrade |
Free Cash Flow Per Share | 2.73 | 1.41 | 1.29 | 1.98 | 1.97 | 1.98 | Upgrade |
Dividend Per Share | 0.240 | 0.480 | 0.480 | 0.480 | 0.480 | 0.480 | Upgrade |
Dividend Growth | -50.00% | - | - | - | - | 20.00% | Upgrade |
Gross Margin | 39.71% | 40.69% | 36.43% | 32.38% | 28.39% | 24.03% | Upgrade |
Operating Margin | 20.49% | 23.38% | 21.18% | 19.04% | 15.62% | 12.76% | Upgrade |
Profit Margin | -1.08% | 4.87% | 12.72% | 13.88% | 14.46% | 10.13% | Upgrade |
Free Cash Flow Margin | 9.70% | 4.42% | 3.41% | 5.58% | 6.52% | 8.48% | Upgrade |
EBITDA | 147.86 | 186.52 | 199.28 | 170.42 | 117 | 63.42 | Upgrade |
EBITDA Margin | 24.26% | 26.51% | 23.82% | 21.78% | 18.67% | 16.04% | Upgrade |
D&A For EBITDA | 23.01 | 21.99 | 22.11 | 21.46 | 19.09 | 12.96 | Upgrade |
EBIT | 124.85 | 164.53 | 177.16 | 148.97 | 97.91 | 50.46 | Upgrade |
EBIT Margin | 20.49% | 23.38% | 21.18% | 19.04% | 15.62% | 12.76% | Upgrade |
Effective Tax Rate | 142.77% | 49.64% | 24.42% | 22.33% | 25.00% | 23.30% | Upgrade |
Advertising Expenses | - | 40.51 | 38.21 | 29.71 | 16.1 | 2.71 | Upgrade |
Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.